Accolade Inc
NASDAQ:ACCD
Accolade Inc
Revenue
Accolade Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Revenue
$363.1m
|
CAGR 3-Years
40%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
Accolade Inc
Revenue Breakdown
Breakdown by Geography
Accolade Inc
Breakdown by Segments
Accolade Inc
Total Revenue:
363.1m
USD
|
Access Fees:
284.1m
USD
|
Utilization-Based Fees:
79m
USD
|
See Also
What is Accolade Inc's Revenue?
Revenue
363.1m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Revenue amounts to 363.1m USD.
What is Accolade Inc's Revenue growth rate?
Revenue CAGR 5Y
36%
Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Accolade Inc have been 40% over the past three years , 36% over the past five years .